Press Releases

12345678910
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026, at 2:00 p.m. ET in New York.
By Spruce Biosciences, Inc. · Via Business Wire · September 8, 2026
Genius Sports, NBA All-Star Chris Paul and Words + Pictures Launch New Athlete-Led Sports Media Company
Genius Sports Limited (“Genius Sports”) (NYSE: GENI), a global leader in sports data and technology, and NBA All-Star and entrepreneur Chris Paul today announced the launch of a new athlete-led sports media company created in partnership with Paul’s Ohh Dip!!! Entertainment and Connor Schell’s Words + Pictures.
By Genius Sports · Via Business Wire · September 8, 2026
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Largest comparative meta-analysis of its kind found da Vinci robotic-assisted surgery was associated with shorter hospital stays and a faster return to work compared with laparoscopic and open surgery
By Intuitive Surgical, Inc. · Via GlobeNewswire · September 8, 2026
Patented NogginLOC Technology Offers an Innovative Approach to Helmet Fastening
Via PRLog · September 8, 2026
Dealerweb LLC Announces Institutional Trade Coordination for Approximately $42.8 Million PG Share Transaction
Via ACN Newswire · September 8, 2026
Rain.gg Expands CS2 Skin Platform with Case Opening, Battles and Marketplace Features
Via ACN Newswire · September 8, 2026
Mandeville Pests May Pose Serious Health Risks for Your Family
Via PRLog · September 8, 2026
Worthington Steel Signs Domination and Profit and Loss Transfer Agreement with Kloeckner & Co SE
Worthington Steel, Inc., (NYSE: WS) announced today that it has signed a domination and profit and loss transfer agreement (“DPLTA”) pursuant to Sections 291 et seq. of the German Stock Corporation Act (AktG) with Kloeckner & Co SE (“Kloeckner”) as the controlled company via its wholly owned subsidiary, Worthington Steel GmbH.
By Worthington Steel, Inc. · Via Business Wire · September 8, 2026
ServiceTitan Names Rikus Pretorius Next Chief Revenue Officer
ServiceTitan Veteran Promoted to Lead Sales Organization Through Next Chapter of Growth; Ross Biestman to Remain at the Company for the Remainder of Fiscal Year
By ServiceTitan · Via GlobeNewswire · September 8, 2026
ServiceTitan Announces Fiscal Second Quarter Financial Results
LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal second quarter ended July 31, 2026.
By ServiceTitan · Via GlobeNewswire · September 8, 2026
Mission Produce® Announces Fiscal 2026 Third Quarter Financial Results
Revenue of $450 million reflects 26% increase over prior year
By Mission Produce, Inc. · Via GlobeNewswire · September 8, 2026
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
WATERTOWN, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, will host a virtual Analyst Day on Monday, September 28, 2026 from 12:00 – 1:30 PM ET featuring presentations and Q&A led by CAMP4’s executive leadership team and participation from patient advocates and a leading KOL. To register, click here.
By CAMP4 Therapeutics · Via GlobeNewswire · September 8, 2026
Clearwater Paper Releases 2026 Sustainability Report Highlighting Progress and Achievements
Clearwater Paper Corporation (NYSE: CLW) today released its 2026 Sustainability Report, providing an annual update on the company's progress toward its multiyear sustainability goals.
By Clearwater Paper Corporation · Via Business Wire · September 8, 2026
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026
DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal fourth quarter and full year ended June 30, 2026.
By InnovAge · Via GlobeNewswire · September 8, 2026
Coherent Brings AI Datacenter and Photonics Thought Leadership to ECOC 2026 in Málaga, Spain
SAXONBURG, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), the global leader in photonics, today announces that its Chief Marketing Officer, Dr. Sanjai Parthasarathi, its Chief Technology Officer, Dr. Julie Sheridan Eng and Dr. Giovanni Barbarossa, Special Advisor to CEO, along with other Coherent experts, will participate in key thought leadership sessions at the European Conference on Optical Communication (ECOC) 2026, to be held September 21 – 23, 2026, in Málaga, Spain.
By Coherent Corp. · Via GlobeNewswire · September 8, 2026
Logitech Shareholders Approve All Board Proposals, Including Increased Dividend, at 2026 Annual General Meeting
Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that during its annual general meeting (AGM) the Company’s shareholders approved a Fiscal Year 2026 cash dividend of CHF 1.36 per share - an increase of CHF 0.10 compared to the previous year’s dividend of CHF 1.26 per share.
By Logitech International · Via Business Wire · September 8, 2026
Carlsmed, Inc. Announces Chief Operating Officer Appointment
CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that Jeff Bertolini has been promoted to the role of Chief Operating Officer, effective immediately. Jeff joined Carlsmed in September 2024, most recently serving as the Company’s Senior Vice President, Operational Excellence and previously, Vice President of Advanced Manufacturing Technologies. Prior to joining Carlsmed, Jeff held senior leadership positions in operations and technology at SI-BONE, NuVasive, and US Surgical.
By Carlsmed · Via GlobeNewswire · September 8, 2026
Suniva Completes $835 Million Capital Raise to Build Second Major U.S. Solar Cell Manufacturing Facility and More Than Quadruple Capacity to 5.5 GW
Suniva, the largest and oldest U.S. merchant manufacturer of high-efficiency monocrystalline silicon solar cells (“Suniva” or the “Company”), today announced the completion of an $835 million capital raise comprising both debt and equity financing. The financing was provided by a group of top-tier financial partners, including Suniva’s largest shareholder and long-term backer, Lion Point Capital, and consists of senior secured credit facilities provided by funds managed by Goldman Sachs Alternatives and I Squared Capital, a second lien credit facility provided by JBA Asset Management, and equity investments by Electron Capital Partners, Orion Infrastructure Capital (OIC), and Rubric Capital Management, along with certain other investors. The new capital will fund construction of Suniva’s second U.S. solar cell manufacturing facility and accelerate the Company’s rapid expansion to a total of 5.5 GW of American-made solar cell capacity, a decisive step toward U.S. energy independence. Roth Capital Partners served as lead private placement agent to Suniva. Gibson, Dunn & Crutcher LLP served as legal counsel to Roth. Rodman & Renshaw served as a financial advisor to Suniva. J.P. Morgan acted as the sole structuring agent to Suniva. Kilpatrick Townsend & Stockton LLP served as legal counsel to Suniva.
By Suniva · Via Business Wire · September 8, 2026
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million
Advancing lead program KRSA-028 toward the clinic, with Phase 1 healthy volunteer data expected mid-2027 and interim proof-of-concept data in Alzheimer’s patients anticipated by year-end 2027 or first quarter of 2028
By Korsana Biosciences · Via GlobeNewswire · September 8, 2026
Barnes & Noble Education Reports Fiscal 2027 First Quarter Financial Results
Quarterly Results Reflect Improved Profitability, First Day® Complete Growth and Continued Balance Sheet Progress
By Barnes & Noble Education, Inc · Via GlobeNewswire · September 8, 2026
Xponential Fitness, Inc. Appoints Jennifer Ryu as Chief Financial Officer
Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”), one of the leading global franchisors of boutique health and wellness brands, today announced the appointment of Jennifer Ryu as Chief Financial Officer, effective as of October 19, 2026, following the previously announced search process. Ms. Ryu will succeed Robert Julian, who has served as interim Chief Financial Officer since March 2026. Mr. Julian will remain a consultant to the Company to ensure a smooth transition.
By Xponential Fitness, Inc. · Via Business Wire · September 8, 2026
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced new clinical data for KRASG12C inhibitor BBO-8520 and the strategic prioritization of (i) BBO-8520 in combination with checkpoint inhibitor in 2L+ KRASG12C inhibitor-experienced non-small cell lung cancer (NSCLC) patients and (ii) BBO-11818 and BBO-10203 combinations in KRAS-mutant cancers.
By TheRas, Inc. (d/b/a BBOT) · Via GlobeNewswire · September 8, 2026
Deadline Approaching: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming November 2, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) securities between December 29, 2025 and June 29, 2026, inclusive (the “Class Period”).
By Law Offices of Howard G. Smith · Via Business Wire · September 8, 2026
Braze Reports Strong Fiscal Second Quarter 2027 Results
Braze (Nasdaq: BRZE), the leading customer engagement platform that empowers brands to Be Absolutely EngagingTM, today announced results for its fiscal quarter ended July 31, 2026.
By Braze · Via Business Wire · September 8, 2026
Our mobile technicians are experts in how to replace windshields
Via PRLog · September 8, 2026
Sea Machines Secures IDIQ Contract with US Special Operations Forces (SOF) for Universal Autonomy Systems
Sea Machines Robotics announced today that it has secured a 5 year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply its commercial, non-developmental, TRL-9, rapidly deployable autonomy kits to US Special Operations Forces. The contract enables SOF to leverage Sea Machines to supply “drop-in” capability for autonomous command and control on global vessels of opportunity to enhance expeditionary logistics, as well as Intelligence, Surveillance and Reconnaissance (ISR) and maritime security at the tactical edge.
By Sea Machines Robotics · Via Business Wire · September 8, 2026
$60K Grant from FHLB Dallas, Austin Bank and Woodforest National Bank Boosts Support for East Texas Entrepreneurs
The Federal Home Loan Bank of Dallas (FHLB Dallas) and its members Austin Bank and Woodforest National Bank® (Woodforest) awarded $60,000 in Partnership Grant Program (PGP) funding to Greater Texas Capital Community Finance, doing business as Lending Avenue®. The funds are part of $1.8 million in PGP funds awarded in 2026 by FHLB Dallas and members in its five-state District of Arkansas, Louisiana, Mississippi, New Mexico and Texas, and will help Lending Avenue expand access to small‑dollar loans, technical assistance and financial education for entrepreneurs across East Texas.
By Federal Home Loan Bank of Dallas · Via Business Wire · September 8, 2026
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Phase 3 LIONHEART-HCM Trial of BHB-1893 in Obstructive Hypertrophic Cardiomyopathy (oHCM) Initiated
By Braveheart Bio, Inc. · Via GlobeNewswire · September 8, 2026
Acquisition of Own Shares
Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information
By Lakefront Biotherapeutics · Via GlobeNewswire · September 8, 2026
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a clinical-stage target oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on September 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 86,500 shares of common stock to four new employees under the Company’s 2024 Inducement Plan. The Compensation Committee approved the stock options as an inducement material to such employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
By Immunome, Inc. · Via Business Wire · September 8, 2026
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City at 5:35pm ET on Tuesday, September 15th, 2026.
By Lakefront Biotherapeutics · Via GlobeNewswire · September 8, 2026
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
Event to be webcast live on September 9, 2026 at 7:30 a.m. ET
By Pyxis Oncology · Via GlobeNewswire · September 8, 2026
Celldex to Present at Upcoming Investor Conference
HAMPTON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on September 10, 2026 at 8:00am ET.
By Celldex Therapeutics, Inc. · Via GlobeNewswire · September 8, 2026
Align Technology to Speak at Upcoming Financial Conference
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately one month.
By Align Technology, Inc. · Via Business Wire · September 8, 2026
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer. Mr. Bailey will join STAAR's executive committee and report to Warren Foust, President and Chief Executive Officer.
By STAAR Surgical Company · Via Business Wire · September 8, 2026
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes –
By Assembly Biosciences, Inc. · Via GlobeNewswire · September 8, 2026
Inventiva to Present Multiple Abstracts at Paris MASH 2026
Daix (France), New York (New York, United States), September 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announces the presentation of five abstracts at the 12th Paris MASH Meeting taking place September 10-11, 2026, at the Pasteur Institut in Paris, France.
By INVENTIVA · Via GlobeNewswire · September 8, 2026
The Education Plan® Encourages Families to Consider 529 Plans in Their Back-to-School Shopping List
Santa Fe, NM, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The Education Plan®—New Mexico’s 529 direct-sold education savings plans—is encouraging New Mexico families to consider another item to the back-to-school shopping list: a 529 plan. 529 education savings plans can be utilized for a variety of qualified expenses at colleges and universities, as well as certain K-12 expenses (including tuition), trade schools, professional education expenses for certification and credentialing, and more.
By The Education Plan · Via GlobeNewswire · September 8, 2026
Maverick Medical AI Brings Revenue Certainty to the Hospital Revenue Cycle
Clinical-to-Revenue Intelligence identifies and addresses revenue-impacting issues from the point of care through claim submission, before they reach the payer
By Maverick Medical AI, Inc. · Via GlobeNewswire · September 8, 2026
CoinShares Announces Date of First Half 2026 Financial Results
JERSEY, Channel Islands, September 8, 2026 (GLOBE NEWSWIRE) -- CoinShares PLC (Nasdaq: CSHR) (“CoinShares” or the “Company”), a leading global asset manager specializing in digital assets operating an institutional-grade platform with integrated Capital Markets capabilities, announced today that it will publish its financial results for the first half of 2026, covering the six months ended June 30, 2026, on Monday, September 14, 2026, before market open.
By CoinShares PLC · Via GlobeNewswire · September 8, 2026
AdaptHealth Appoints Harriss Currie as Chief Financial Officer
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chief Financial Officer, effective September 9, 2026. Mr. Currie will assume CFO responsibilities from Jason Clemens, who will assist with the transition through October 1, 2026.
By AdaptHealth Corp. · Via Business Wire · September 8, 2026
Oahu Roofing & Repairs Expands 24/7 Emergency Roof Repair and Insurance Claim Support on Oahu
Oahu Roofing & Repairs is helping island homeowners and businesses respond to storm damage with rapid roof repairs and hands-on insurance claim assistance.
Via PRUnderground · September 8, 2026
Patch My PC Partners with QBS Software to Expand Automated Application Management and Security Solutions Across EMEA
Patch My PC, a leading provider of automated third-party application management and patching solutions, today announced a strategic partnership with QBS Software, one of EMEA’s largest value-added distributors, to expand access to automated application management and security solutions for resellers, MSPs and technology partners across the region.
By Patch My PC · Via Business Wire · September 8, 2026
The Embody Lab Leads New Comparison of Breathwork Certification Programs
NEW YORK - September 08, 2026 - The Embody Lab, an online education platform for mental health practitioners and healing-curious individuals, today released its ranking of the seven breathwork certification programs mental health professionals are turning to for trauma-informed, nervous-system-focused training in 2026. The list evaluates programs on clinical grounding, faculty credentials, and how well breathwork instruction integrates with broader somatic and polyvagal-informed practice. The Embody Lab holds the top position.
Via AB Newswire · September 8, 2026
The Embody Lab’s Somatic Certificate Leads 2026 Trauma-CE Rankings
NEW YORK - September 08, 2026 - The Embody Lab, an online education platform built for mental health practitioners and healing-curious professionals, today released its ranking of the eight trauma-informed care certification programs therapists are choosing in 2026 — a list built around CE accreditation, somatic methodology, and practitioner-reported depth of clinical application.
Via AB Newswire · September 8, 2026
Black Tech Week Selects Columbus as 2027 Host City
Columbus, Ohio, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Black Tech Week, presented by JobsOhio, one of the nation’s leading gatherings for founders, investors, technologists, creatives and ecosystem builders, has selected Columbus as its host city for 2027. The announcement was made Friday, Sept. 4, on stage during CBUS Soul® Fest, a free, two-day celebration of Columbus’ vibrant Black culture, presented in partnership by Experience Columbus and Columbus Recreation and Parks Department.   Black Tech Week will be held in the summer of 2027, bringing a national audience of founders, creators, investors, Fortune 500 executives, technologists and culture-shapers to Columbus for the first time. More than 100 speakers, panels and workshops focused on the future of technology and entrepreneurship will take place.  “When we launched Black Tech Week in 2022, our vision was to build a nationally recognized platform that connected founders, creatives and innovators from across the country and around the world,” said Candice Matthews Brackeen, Founder and CEO of Lightship Foundation. “As we look toward the future, Columbus offers an incredible opportunity to expand our reach and create even greater impact.”  Black Tech Week is expected to have a significant impact on Columbus, welcoming approximately 7,500-10,000 attendees and bringing in an estimated $5.4 million in direct visitor spending.   “Black Tech Week’s decision to make Columbus its next home is a landmark win for our city, and we are incredibly grateful for the opportunity,” said Brian Ross, President and CEO of Experience Columbus. “Indeed reports local tech job growth at twice the national rate, and The New York Times recently recognized our region as ‘a critical hub for advanced manufacturing and artificial intelligence,’ making Columbus a natural fit for this monumental gathering. We’re eager to welcome attendees next summer.”  Black Tech Week was founded in Miami in 2013 with its inaugural conference taking place in 2015 and has been held in Cincinnati annually since 2022. The event has featured prominent keynote speakers including Serena Williams, Ava DuVernay, Keke Palmer and more. The conference creates opportunities for emerging entrepreneurs and established industry leaders to exchange ideas, build relationships and explore the technologies and businesses shaping the future.   “Lightship Foundation continues to grow the Black Tech Week conference in Ohio, reflecting the momentum of our state’s innovation economy as a place where entrepreneurs, investors and industry leaders come together to build what’s next,” said JobsOhio President and CEO J.P. Nauseef. “This event will continue to be a leading opportunity to build relationships and connect founders to the resources across Ohio that fuel long-term growth.”  Additional information, venue details and ticket information for Black Tech Week 2027 will be announced in the coming months. Learn more about Black Tech Week by visiting blacktechweek.com.   
By Experience Columbus · Via GlobeNewswire · September 8, 2026
US Medical Directors Publishes 2026 Medspa Oversight Provider List
NEW YORK - September 08, 2026 - US Medical Directors, a provider of medical director oversight, good faith exams, chart review, and collaborating physician services for aesthetic professionals, today released its ranking of the seven medical director and collaborating physician services medspas rely on most in 2026 — a list built around aesthetics-specific compliance rather than general physician staffing.
Via AB Newswire · September 8, 2026
US Medical Directors Recognized Among Leading Collaborating Physician Services of 2026
NEW YORK - September 08, 2026 - US Medical Directors, a physician oversight and collaborating physician service built specifically for aesthetic professionals, today released its 2026 ranking of the top collaborating physician services for nurse practitioners — a list built around scope-of-practice compliance, good faith exam coverage, and chart review turnaround rather than marketing claims. The ranking places US Medical Directors at #1, citing its dedicated focus on aesthetics-only oversight across dozens of U.S. states and its bulk-purchasing model for medspa and nurse members.
Via AB Newswire · September 8, 2026
Farm Progress Show 2026 delivers excellence as global destination for ag tech and innovation
International product unveilings, research-grade agronomy demonstrations and cutting-edge innovation draw farmers from across the world.
By Farm Progress · Via GlobeNewswire · September 8, 2026
HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent
Americans can connect their health history to Muse using HealthEx and make progress on their health goals with a plan that adapts to their life as their clinical context changes
By HealthEx · Via GlobeNewswire · September 8, 2026